Cargando…

The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study

BACKGROUND: There is wide global variance in survival from breast cancer, both in developed and developing country. However, the effect of estrogen receptor status has not been widely evaluated in Ethiopia where the incidence of breast cancer is rapidly increasing. Hence, the current study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Belete, Abebe Muche, Aynalem, Yared Asmare, Gemeda, Belete Negese, Demelew, Tefera Mulugeta, Shiferaw, Wondimeneh Shibabaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211074/
https://www.ncbi.nlm.nih.gov/pubmed/35747466
http://dx.doi.org/10.2147/BCTT.S365295
_version_ 1784730284876365824
author Belete, Abebe Muche
Aynalem, Yared Asmare
Gemeda, Belete Negese
Demelew, Tefera Mulugeta
Shiferaw, Wondimeneh Shibabaw
author_facet Belete, Abebe Muche
Aynalem, Yared Asmare
Gemeda, Belete Negese
Demelew, Tefera Mulugeta
Shiferaw, Wondimeneh Shibabaw
author_sort Belete, Abebe Muche
collection PubMed
description BACKGROUND: There is wide global variance in survival from breast cancer, both in developed and developing country. However, the effect of estrogen receptor status has not been widely evaluated in Ethiopia where the incidence of breast cancer is rapidly increasing. Hence, the current study aimed to determine the effect of estrogen receptor status on the overall survival of breast cancer patients who were treated at Black Lion Specialized Hospital, Ethiopia. METHODS: In this institution-based retrospective cohort study a total of 368 study participants were included with a one-to-one ratio of estrogen receptor negative to estrogen receptor positive. The main outcome of interest for this study was death due to breast cancer. The authors compared the women with estrogen receptor-positive and estrogen receptor-negative breast cancer for overall survival rate using log rank test. The incidence density rate of mortality was calculated for each exposed and non-exposed variable. The effect of estrogen receptor status on breast cancer mortality was estimated using the Cox proportional hazards model. RESULTS: The incidence density rate of mortality among breast cancer patients for estrogen receptor positive were found to be 5.48 (95% CI=3.94–7.64) per 1,000 person years observation; while for estrogen negative receptor status the mortality rate was found to be 10.47 (95% CI=8.19–13.37) per 1,000 person years observation. In the Cox regression analysis after ful adjustments for confounder variables, the mortality event risk was 32% higher among estrogen receptor negative (HR=1.32; 95% CI=1.08–2.91) as compared to estrogen receptor positive breast cancer patients. CONCLUSION: We have found that the incidence density rate of mortality among breast cancer patients was significantly higher in the estrogen receptor negative groups. Therefore, clinicians should give careful attention to the impact of estrogen receptor negative status on the overall outcome of clients.
format Online
Article
Text
id pubmed-9211074
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-92110742022-06-22 The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study Belete, Abebe Muche Aynalem, Yared Asmare Gemeda, Belete Negese Demelew, Tefera Mulugeta Shiferaw, Wondimeneh Shibabaw Breast Cancer (Dove Med Press) Original Research BACKGROUND: There is wide global variance in survival from breast cancer, both in developed and developing country. However, the effect of estrogen receptor status has not been widely evaluated in Ethiopia where the incidence of breast cancer is rapidly increasing. Hence, the current study aimed to determine the effect of estrogen receptor status on the overall survival of breast cancer patients who were treated at Black Lion Specialized Hospital, Ethiopia. METHODS: In this institution-based retrospective cohort study a total of 368 study participants were included with a one-to-one ratio of estrogen receptor negative to estrogen receptor positive. The main outcome of interest for this study was death due to breast cancer. The authors compared the women with estrogen receptor-positive and estrogen receptor-negative breast cancer for overall survival rate using log rank test. The incidence density rate of mortality was calculated for each exposed and non-exposed variable. The effect of estrogen receptor status on breast cancer mortality was estimated using the Cox proportional hazards model. RESULTS: The incidence density rate of mortality among breast cancer patients for estrogen receptor positive were found to be 5.48 (95% CI=3.94–7.64) per 1,000 person years observation; while for estrogen negative receptor status the mortality rate was found to be 10.47 (95% CI=8.19–13.37) per 1,000 person years observation. In the Cox regression analysis after ful adjustments for confounder variables, the mortality event risk was 32% higher among estrogen receptor negative (HR=1.32; 95% CI=1.08–2.91) as compared to estrogen receptor positive breast cancer patients. CONCLUSION: We have found that the incidence density rate of mortality among breast cancer patients was significantly higher in the estrogen receptor negative groups. Therefore, clinicians should give careful attention to the impact of estrogen receptor negative status on the overall outcome of clients. Dove 2022-06-17 /pmc/articles/PMC9211074/ /pubmed/35747466 http://dx.doi.org/10.2147/BCTT.S365295 Text en © 2022 Belete et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Belete, Abebe Muche
Aynalem, Yared Asmare
Gemeda, Belete Negese
Demelew, Tefera Mulugeta
Shiferaw, Wondimeneh Shibabaw
The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study
title The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study
title_full The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study
title_fullStr The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study
title_full_unstemmed The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study
title_short The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study
title_sort effect of estrogen receptor status on survival in breast cancer patients in ethiopia. retrospective cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211074/
https://www.ncbi.nlm.nih.gov/pubmed/35747466
http://dx.doi.org/10.2147/BCTT.S365295
work_keys_str_mv AT beleteabebemuche theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy
AT aynalemyaredasmare theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy
AT gemedabeletenegese theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy
AT demelewteferamulugeta theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy
AT shiferawwondimenehshibabaw theeffectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy
AT beleteabebemuche effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy
AT aynalemyaredasmare effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy
AT gemedabeletenegese effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy
AT demelewteferamulugeta effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy
AT shiferawwondimenehshibabaw effectofestrogenreceptorstatusonsurvivalinbreastcancerpatientsinethiopiaretrospectivecohortstudy